Variable

Mean survival time (months)

1-year OS

3-year OS

5-year OS

P value

Site of recurrence

<0.001

Intrahepatic

56.1 ± 3.3

73.4%

37.0%

27.2%

Extrahepatic

24.2 ± 3.8

68.6%

20.6%

0

Intrahepatic and extrahepatic

20.0 ± 4.4

57.1%

3.3%

0

Tumor nodules

<0.001

Single

72.3 ± 4.8

81.8%

46.5%

39.2%

Mutiple

31.2 ± 2.9

61.3%

20.9%

10.1%

Tumor thrombus

<0.001

Yes

18.0 ± 4.7

40.0%

10.0%

5.0%

No

55.6 ± 3.2

74.7%

36.3%

26.7%

Clinical stages

<0.001

Early stage

70.7 ± 4.7

82.0%

46.8%

37.3%

Intermediate stage

42.8 ± 5.7

73.2%

31.8%

15.9%

Advanced stage

25.1 ± 3.1

55.5%

14.2%

0

Terminal stage

6.5 ± 3.4

10.0%

0

0

Treatment strategies

<0.001

RR

73.0 ± 8.1

94.0%

48.5%

38.4%

LAT

83.1 ± 9.3

84.7%

52.0%

16.7%

TACE

47.3 ± 3.6

67.3%

30.1%

21.2%

Radiotherapy

27.0 ± 7.0

64.7%

11.8%

0

Palliative treatment

11.3 ± 2.2

34.4%

3.1%

0

Disease-free interval

<0.001

≤1 year

37.9 ± 3.0

60.5%

23.9%

16.1%

>1 years

73.6 ± 9.2

91.8%

52.9%

39.5%